New drug trial targets Tough-to-Treat cancers that spread to the brain
Disease control
Recruiting now
This is the first study in people to test a new oral drug called AO-252 for advanced solid tumors, including cancers that have spread to the brain. The main goals are to find a safe dose and see how well the body handles the drug. It will involve about 86 adults whose cancer has …
Phase: PHASE1 • Sponsor: A2A Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 02, 2026 01:42 UTC